Struggling with the itch caused by eczema?
Researchers at Stanford are partnering with adults who have atopic dermatitis (eczema) and moderate to severe pruritis (itchy skin) to learn if taking an oral medication in addition to a topical corticosteroid cream can reduce the intensity of their itching. Join our paid research study today!
Conducted in California Bay Area
Compensation Provided
Itchy skin for 6+ weeks
18-80 years old
Quick Overview
Diagnosed with Atopic Dermatitis (eczema)
Study Background
Our researchers want to investigate a possible treatment for itchy skin caused by eczema.

Atopic dermatitis, commonly known as eczema, is the most common chronic inflammatory skin disease. One hallmark of eczema is pruritis, or itchy skin, driving the "itch-scratch cycle" that further damages the skin. This study aims to treat pruritus using an oral medication called difelikefalin in combination with a topical corticosteroid (TCS) cream.

You may qualify to enroll if you have eczema and have had pruritis for the last six weeks or more. Participating in this research study may help researchers develop better treatment strategies for eczema. Join our compensated study today!
Additional Information